Abstract
Alzheimer's disease (AD) is the most prevalent form of dementia affecting the elderly. Neurodegeneration is caused by the amyloid beta (Aβ) peptide which is generated from the sequential proteolytic cleavage of the Amyloid Precursor Protein (APP) by the β– and γ- secretases. Previous reports revealed that the 37 kDa/67 kDa laminin receptor (LRP/LR) is involved in APP processing, however, the exact mechanism by which this occurs remains largely unclear. This study sought to assess whether LRP/LR interacted with APP, β- or γ-secretase. Detailed confocal microscopy revealed that LRP/LR showed a strong co-localisation with APP, β- and γ-secretase, respectively, at various sub-cellular locations. Superresolution Structured Illumination Microscopy (SR-SIM) showed that interactions were unlikely between LRP/LR and APP and β-secretase, respectively, while there was strong co-localisation between LRP/LR and γ-secretase at this 80 nm resolution. FRET was further employed to assess the possibility of protein-protein interactions and only an interaction between LRP/LR and γ-secretase was found. FLAG co-immunoprecipitation confirmed these findings as LRP/LR co-immunoprecipitated with γ-secretase, but failed to do so with APP. These findings indicate that LRP/LR exerts its influence on Aβ shedding via a direct interaction with the γ-secretase and possibly an indirect interaction with the β-secretase.
Highlights
Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder affecting the elderly population worldwide
The cellular localisations of LRP/LR variant (LRP)/LR are limited to these same regions and the presence of this protein has been noted in the Golgi apparatus [34]
The co-localisation observed from the maximum intensity projection between PS1-GFP and LRP-dsRed supports the notion that LRP/LR and c-secretase appear to be located in similar cellular regions and compartments in HEK293 cells (Figure 1A)
Summary
Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder affecting the elderly population worldwide. Lack of understanding of the disease causing mechanisms have resulted in great difficulties in the development of effective therapeutic interventions and as yet, the only treatment strategies are merely palliative, despite numerous ongoing clinical trials [3]. Oligomeric Ab is thought to be the candidate etiological agent for AD since it has been found to mediate neurotoxicity through interactions with many other proteins [4,5]. One such protein that has proved to be of significance in AD is the cellular prion protein (PrPc)
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have